FDA Approvals to Fuel the Demand for Biosimilars in Oncology
Biosimilars are gaining major application in the healthcare sector owing to their advanced benefits and cost-effectiveness compared to the other biologics. Although biologics represent the fastest growing segments of cancer treatment and are recommended for treating cancer as a part of the supportive care that helps in treating side effects of the disease, rising cost of cancer treatments are leading to opt for lower cost solutions and budget-friendly treatments.
View full press release